ClinicalTrials.Veeva

Menu

Examination of the Pancreas in New-onset Diabetes (EXPAND)

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Diabetes Mellitus

Treatments

Other: medical chart review
Other: survey administration
Other: Specimen collection

Study type

Observational

Funder types

Other

Identifiers

NCT02001337
10-006868

Details and patient eligibility

About

The purpose of this study is to create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and then screen this cohort for pancreatic cancer

Full description

Compared to the general population, subjects >50 years of age with new-onset diabetes (DM) are 8-times more likely to have pancreatic cancer (PaC). The likelihood of PaC in new-onset DM is further increased in those who have weight loss or elevated CA19-9. In this study patients with newly diagnosed diabetes will be prospectively identified. Those with weight loss and/or elevated pancreatic cancer marker (CA 19-9) will undergo pancreatic imaging. All subjects will be followed up to 24 months. If successful in identifying surgically removable PaC, this study will fundamentally change our practice and will be a major breakthrough in PaC treatment and research.

Enrollment

79 patients

Sex

All

Ages

50 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Patient Characteristics:

--Suspected or definite new-onset diabetes based on recent blood sugar and hemoglobin A1c values

  • No acute illness or steroid therapy
  • No prior pancreas surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems